Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-26

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Panacea Biotec Limited)

View source ↗

Summary

FDA approved a supplemental application for Rizatriptan Benzoate by Panacea Biotec Limited. The approval makes a generic rizatriptan benzoate product available …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)